Key advances in ovarian cancer (ASCO 2010 ) Video
Links shared publicly online about this topic.
- 1,003total visits
Key advances in ovarian cancer (ASCO 2010 ) Video
View full resource at vodpod.com
Tags: Cancer, Chemotherapy, Colorectal Cancer Medication, Ovarian Cancer, Women's Health, Avastin
Most Recently Shared on July 22, 2010 at 9:59 pm By:
Prof Jonathan Ledermann outlines some of the key advances in ovarian cancer that have been presented at ASCO 2010. Pro… http://bit.ly/b7acun
Ovarian cancer research (ASCO 2010) Video
vodpod.com — “Prof Kaye talks about the future of ovarian cancer research. One area that is expected to be very important is research targeting the VEGF protein. A key presentation at ASCO 2010 has shown that a maintenance treatment of avastin, a targeted therapy that blocks VEGF, increases overall survival in ovarian cancer patients. The second area discussed is research into PARP inhibitors. After some spectacular initial results in women with BRCA mutations, a trial presented at ASCO 2010 has shown that ol” View full resource at vodpod.com
Most Recently Shared on July 21, 2010 at 5:00 am By:
Paul Cacciatore Patient Advocate
Prof Kaye talks about the future of ovarian cancer research. One area that is expected to be very important is researc… http://bit.ly/bROVq0
ASCO Cancer Drug Treatment Research Highlights Oncology Conference | PBS NewsHour | June 7, 2010 | PBS Video
vodpod.com — “Researchers reported new progress in the treatment of breast, skin, lung and ovarian cancers at a weekend meeting of top cancer experts in Chicago. Ray Suarez talks to American Society of Clinical Oncology President George Sledge for an update on the new medical advances. 08 Jun 10. Researchers reported new progress in the treatment of breast, skin, lung and ovarian cancers at a weekend meeting of top cancer experts in Chicago. Ray Suarez talks to American Society of Clinical Oncology President ” View full resource at vodpod.com
Most Recently Shared on June 8, 2010 at 3:42 pm By:
Paul Cacciatore Patient Advocate
Researchers reported new progress in the treatment of breast, skin, lung and ovarian cancers at a weekend meeting of t… http://bit.ly/bB3nVl
2010 ASCO: GOG-218 Avastin Study Results Video
vodpod.com — “Dr. Jennifer Obel talks about GOG 218 Avastin ovarian cancer study results presented at the 2010 ASCO Annual Meeting. For more information, visit Cancer.Net (http://www.cancer.net). 07 Jun 10. Dr. Jennifer Obel talks about some of the advances in ovarian cancer care coming out of the 2010 ASCO Annual Meeting. For more information, visit Cancer.Net ...” View full resource at vodpod.com
Most Recently Shared on June 7, 2010 at 5:39 pm By:
Paul Cacciatore Patient Advocate
Dr. Jennifer Obel talks about GOG 218 Avastin ovarian cancer study results presented at the 2010 ASCO Annual Meeting. … http://bit.ly/9w1PLC
2010 ASCO TV: GOG-218 Study of Avastin Video
vodpod.com — “ASCO Daily News presents an exclusive clip from Dr. Robert A. Burger's presentation, "Phase III trial of bevacizumab (BEV) in the primary treatment of advanced epithelial ovarian cancer (EOC), primary peritoneal cancer (PPC), or fallopian tube cancer (FTC): A Gynecologic Oncology Group study," during yesterday's Plenery Session (LBA1). 07 Jun 10.” View full resource at vodpod.com
Most Recently Shared on June 7, 2010 at 4:41 pm By:
Paul Cacciatore Patient Advocate
ASCO Daily News presents an exclusive clip from Dr. Robert A. Burger's presentation, "Phase III trial of bevacizumab (… http://bit.ly/d9sWPv
2010 ASCO: Biologic Agent Reduces Ovarian Cancer Relapse Risk - in Meeting Coverage, ASCO from MedPage Today Video
vodpod.com — “Maintenance therapy with a targeted agent significantly reduced the risk of relapse in women with advanced ovarian and related cancers, a researcher said here. Maintenance therapy with bevacizumab (Avastin) after standard chemotherapy decreased the risk of progression by 28% compared with chemo alone, according to Robert Burger, MD, of Fox Chase Cancer Center in Philadelphia. The approach should now be considered "one standard option" for women with advanced epithelial ovarian, primary” View full resource at vodpod.com
Most Recently Shared on June 6, 2010 at 10:58 pm By:
Paul Cacciatore Patient Advocate
Maintenance therapy with a targeted agent significantly reduced the risk of relapse in women with advanced ovarian and… http://bit.ly/dmsYS9
Does Bevacizumab Improve Outcomes in Advanced Ovarian Cancer? Video
vodpod.com — “Maurie Markman, M.D. (M.D. Anderson Cancer Ctr.) discusses important gynecologic abstracts to be presented at the 2010 Annual ASCO Mtg. to be held June 4-8, 2010. 04 June 10. : Dr. Maurie Markman previews the findings of the latest Gynecologic Oncology Group study as well as a provocative but preliminary study on the value of screening for ovarian cancer.” View full resource at vodpod.com
Most Recently Shared on June 4, 2010 at 4:47 pm By:
Paul Cacciatore Patient Advocate
Maurie Markman, M.D. (M.D. Anderson Cancer Ctr.) discusses important gynecologic abstracts to be presented at the 2010… http://bit.ly/a2FqDg
Advertisement
